The executor caspase expression level was increased in A549 lung cancer cell lines treated with both AgNPs and cisplatin but the caspase-3 expression level showed a significant increase only in AgNPs-treated cells (Fig. 9a). The gene discussed is CASP3; the disease is lung cancer.